Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-13
2008-05-13
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S251000
Reexamination Certificate
active
10567797
ABSTRACT:
This invention relates to novel compounds having formula: (I) or (II) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis ofH. pyloriinfection.
REFERENCES:
patent: WO 03/002567 (2003-01-01), None
patent: WO 2005/016929 (2005-02-01), None
Abdelhamid, et al., A Facile Synthesis of Pyrimido[2″,3″:5′,1′]pyrazolo[3′,4′:4,5]pyrimido[1,6-a]benzimidazoles and [1,2,4]triazino[3″,4″:5′,1′]pyrazolo[3′,4′:4,5]-pyrimido[6,1-a]benzimidazoles, Indian Journal of Chemistry, vol. 40B, 284-89 (2001).
Ghorab, Moustafa M, Synthesis and Radiation Stability of some new biologically active pyrazolo [3,4-d]pyrimidines, 2000, pp. 93-110, National Center for Radiation Research and Technology, Egypt.
Basarab Gregory
Eyermann Charles Joseph
Gowravaram Madhu
Green Oluyinka
Kiely Andrew
AstraZeneca AB
Leeser Erich
Wilson James O.
LandOfFree
Fused heterocycles as inhibitors of glutamate racemase(MURI) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused heterocycles as inhibitors of glutamate racemase(MURI), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused heterocycles as inhibitors of glutamate racemase(MURI) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3905550